These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 26232149)

  • 1. Increased circulating interleukin-17 levels in preeclampsia.
    Molvarec A; Czegle I; Szijártó J; Rigó J
    J Reprod Immunol; 2015 Nov; 112():53-7. PubMed ID: 26232149
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum heat shock protein 70 levels in relation to circulating cytokines, chemokines, adhesion molecules and angiogenic factors in women with preeclampsia.
    Molvarec A; Szarka A; Walentin S; Beko G; Karádi I; Prohászka Z; Rigó J
    Clin Chim Acta; 2011 Oct; 412(21-22):1957-62. PubMed ID: 21756887
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum leptin levels in relation to circulating cytokines, chemokines, adhesion molecules and angiogenic factors in normal pregnancy and preeclampsia.
    Molvarec A; Szarka A; Walentin S; Beko G; Karádi I; Prohászka Z; Rigó J
    Reprod Biol Endocrinol; 2011 Sep; 9():124. PubMed ID: 21906313
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in circulating concentrations of soluble fms-like tyrosine kinase-1 and placental growth factor measured by automated electrochemiluminescence immunoassays methods are predictors of preeclampsia.
    Leaños-Miranda A; Campos-Galicia I; Isordia-Salas I; Rivera-Leaños R; Romero-Arauz JF; Ayala-Méndez JA; Ulloa-Aguirre A
    J Hypertens; 2012 Nov; 30(11):2173-81. PubMed ID: 22902831
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating angiogenic factors determined by electrochemiluminescence immunoassay in relation to the clinical features and laboratory parameters in women with pre-eclampsia.
    Molvarec A; Szarka A; Walentin S; Szucs E; Nagy B; Rigó J
    Hypertens Res; 2010 Sep; 33(9):892-8. PubMed ID: 20535121
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cause-effect relatioships between circulating placental angiogenic proteins and serum IL-2, IL-6 and IL-10 levels in pregnant women with preeclampsia].
    Dimitrakova E; Milchev N; Batashki I; Karumanchi SA
    Akush Ginekol (Sofiia); 2007; 46(9):4-8. PubMed ID: 18642556
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum soluble FMS-like tyrosine kinase 1 and placental growth factor concentration as predictors of preeclampsia in high risk pregnant women.
    Hanita O; Alia NN; Zaleha AM; Nor Azlin MI
    Malays J Pathol; 2014 Apr; 36(1):19-26. PubMed ID: 24763231
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of a new and automated electrochemiluminescence immunoassay for plasma sFlt-1 and PlGF levels in women with preeclampsia.
    Ohkuchi A; Hirashima C; Suzuki H; Takahashi K; Yoshida M; Matsubara S; Suzuki M
    Hypertens Res; 2010 May; 33(5):422-7. PubMed ID: 20150910
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated serum sFlt-1/Ang-2 ratio in women with preeclampsia.
    Hirokoshi K; Maeshima Y; Kobayashi K; Matsuura E; Sugiyama H; Yamasaki Y; Masuyama H; Hiramatsu Y; Makino H
    Nephron Clin Pract; 2007; 106(1):c43-50. PubMed ID: 17409768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urinary angiogenic factors cluster hypertensive disorders and identify women with severe preeclampsia.
    Buhimschi CS; Norwitz ER; Funai E; Richman S; Guller S; Lockwood CJ; Buhimschi IA
    Am J Obstet Gynecol; 2005 Mar; 192(3):734-41. PubMed ID: 15746665
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The sFlt-1/PlGF ratio in different types of hypertensive pregnancy disorders and its prognostic potential in preeclamptic patients.
    Verlohren S; Herraiz I; Lapaire O; Schlembach D; Moertl M; Zeisler H; Calda P; Holzgreve W; Galindo A; Engels T; Denk B; Stepan H
    Am J Obstet Gynecol; 2012 Jan; 206(1):58.e1-8. PubMed ID: 22000672
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decreased circulating anandamide levels in preeclampsia.
    Molvarec A; Fügedi G; Szabó E; Stenczer B; Walentin S; Rigó J
    Hypertens Res; 2015 Jun; 38(6):413-8. PubMed ID: 25716652
    [TBL] [Abstract][Full Text] [Related]  

  • 13. OS004. A link between the complement system and angiogenic imbalance inpreeclampsia: ficolin-2 deficiency.
    Molvarec A; Halmos A; Szijártó J; Csuka D; Füst G; Prohászka Z; Rigó J
    Pregnancy Hypertens; 2012 Jul; 2(3):177. PubMed ID: 26105219
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fractional excretion of angiogenic factors in women with severe preeclampsia.
    Buhimschi CS; Magloire L; Funai E; Norwitz ER; Kuczynski E; Martin R; Richman S; Guller S; Lockwood CJ; Buhimschi IA
    Obstet Gynecol; 2006 May; 107(5):1103-13. PubMed ID: 16648417
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New gestational phase-specific cutoff values for the use of the soluble fms-like tyrosine kinase-1/placental growth factor ratio as a diagnostic test for preeclampsia.
    Verlohren S; Herraiz I; Lapaire O; Schlembach D; Zeisler H; Calda P; Sabria J; Markfeld-Erol F; Galindo A; Schoofs K; Denk B; Stepan H
    Hypertension; 2014 Feb; 63(2):346-52. PubMed ID: 24166751
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating levels of the anti-angiogenic thrombospondin 2 are elevated in pre-eclampsia.
    Stenczer B; Molvarec A; Veresh Z; Gullai N; Nagy GR; Walentin S; Szijártó J; Rigó J
    Acta Obstet Gynecol Scand; 2011 Nov; 90(11):1291-5. PubMed ID: 21682699
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PP037. Relationship of serum leptin levels to circulating cytokines, chemokines, adhesion molecules and angiogenic factors in women with preeclampsia.
    Rigó J; Szarka A; Molvarec A
    Pregnancy Hypertens; 2013 Apr; 3(2):80. PubMed ID: 26105893
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating angiogenic factors and their association with birth outcomes in preeclampsia.
    Kulkarni AV; Mehendale SS; Yadav HR; Kilari AS; Taralekar VS; Joshi SR
    Hypertens Res; 2010 Jun; 33(6):561-7. PubMed ID: 20224572
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Altered angiogenesis in preeclampsia: evaluation of a new test system for measuring placental growth factor.
    Schmidt M; Dogan C; Birdir C; Callies R; Kuhn U; Gellhaus A; Janetzko A; Kimmig R; Kasimir-Bauer S
    Clin Chem Lab Med; 2007; 45(11):1504-10. PubMed ID: 17970705
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extra-placental expression of vascular endothelial growth factor receptor-1, (Flt-1) and soluble Flt-1 (sFlt-1), by peripheral blood mononuclear cells (PBMCs) in normotensive and preeclamptic pregnant women.
    Rajakumar A; Michael HM; Rajakumar PA; Shibata E; Hubel CA; Karumanchi SA; Thadhani R; Wolf M; Harger G; Markovic N
    Placenta; 2005 Aug; 26(7):563-73. PubMed ID: 15993706
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.